Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United KingdomIrelandUnited States (current)New ZealandCanadaAustraliaScotlandNorthern Ireland

← US public companies

Grossman William

SEC-identified person · CIK 1730229 Identifier-verified

Public-company roles (from insider filings)

CompanyCapacity as filedFilings
Engene Therapeutics Inc. ENGN Director · Interim Chief Medical Officer filed 2025 - 2026
Day One Biopharmaceuticals, Inc. DAWN Director filed 2024 - 2026
Arcus Biosciences, Inc. RCUS Chief Medical Officer filed 2019 - 2021
Bellicum Pharmaceuticals, INC BLCM Sr. VP, Chief Medical Officer filed 2018 - 2019

All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.